TIAA CREF Investment Management’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-142,922
| Closed | -$25.7M | – | 3108 |
|
|
2017
Q3 | $25.7M | Sell |
142,922
-3,081
| -2% | -$429K | 0.02% | 659 |
|
|
2017
Q2 | $15.1M | Buy |
146,003
+18,665
| +15% | +$1.52M | 0.01% | 896 |
|
|
2017
Q1 | $9.99M | Sell |
127,338
-10,420
| -8% | -$644K | 0.01% | 1128 |
|
|
2016
Q4 | $6.18M | Sell |
137,758
-20,952
| -13% | -$1.03M | ﹤0.01% | 1465 |
|
|
2016
Q3 | $8.87M | Sell |
158,710
-8,941
| -5% | -$498K | 0.01% | 1202 |
|
|
2016
Q2 | $8.38M | Buy |
167,651
+9,533
| +6% | +$468K | 0.01% | 1167 |
|
|
2016
Q1 | $7.26M | Buy |
158,118
+865
| +0.6% | +$41.9K | 0.01% | 1247 |
|
|
2015
Q4 | $9.69M | Sell |
157,253
-8,175
| -5% | -$575K | 0.01% | 1090 |
|
|
2015
Q3 | $9.21M | Buy |
165,428
+37,523
| +29% | +$2.36M | 0.01% | 1096 |
|
|
2015
Q2 | $7.8M | Buy |
127,905
+64,112
| +101% | +$3.66M | 0.01% | 1342 |
|
|
2015
Q1 | $3.68M | Buy |
63,793
+33,824
| +113% | +$2.27M | ﹤0.01% | 1845 |
|
|
2014
Q4 | $1.73M | Buy |
29,969
+3,238
| +12% | +$136K | ﹤0.01% | 2346 |
|
|
2014
Q3 | $762K | Buy |
+26,731
| New | +$661K | ﹤0.01% | 2790 |
|
TIAA CREF Investment Management's KITE Position: Q4 2017 in Review
TIAA CREF Investment Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 142,922 shares — an estimated $25.7M sold.
TIAA CREF Investment Management first reported a position in KITE in Q3 2014 and held it in 13 quarters. The position peaked at $25.7M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.
- TIAA CREF Investment Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
- TIAA CREF Investment Management sold 142,922 Kite Pharma, Inc. shares in Q4 2017, an estimated $25.7M.
- TIAA CREF Investment Management first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 13 quarters.
- TIAA CREF Investment Management's Kite Pharma, Inc. position peaked at $25.7M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.
Based on TIAA CREF Investment Management's 13F filing for Q4 2017, filed 14 Feb 2018.